The Peruvian Registry of Clinical Trials (REPEC) published a notification (PRESS RELEASE No. 005-2022-OGITT/INS) on January 26, 2022, stating that-
- From January 06, 2022 (the date since which REPEC Version 2 [V2] is out of service), until the REPEC V2 system is enabled again, all documents must be directed to [email protected] and [email protected] emails.
- Once the system’s services are restored, this documentation must be regularized in the REPEC V2.